Cargando…
Cost Analysis of Using a Closed-System Transfer Device (CSTD) for Antineoplastic Drug preparation in a Malaysian Government-Funded Hospital
BACKGROUND: Apart from reducing occupational exposure to cytotoxic hazards, the PhaSeal® closed-system transfer device (CSTD) can extend the beyond-use dates (BUDs) of unfinished vials of antineoplastic drugs for up to 168 hours (seven days). In this study, the total material cost incurred by its us...
Autores principales: | Chan, Huan Keat, Lim, Yik Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454702/ https://www.ncbi.nlm.nih.gov/pubmed/28032722 http://dx.doi.org/10.22034/APJCP.2016.17.11.4951 |
Ejemplares similares
-
Understanding and Challenges in Taking Tyrosine Kinase Inhibitors among Malaysian Chronic Myeloid Leukemia Patients: A Qualitative Study
por: Lim, Yik Ming, et al.
Publicado: (2017) -
Effectiveness of Closed System Drug Transfer Devices in Reducing Leakage during Antineoplastic Drugs Compounding
por: Piccardo, Maria Teresa, et al.
Publicado: (2021) -
Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel Study
por: Simon, Nicolas, et al.
Publicado: (2016) -
Pension Fund Governance
Publicado: (2016) -
Pension Fund Appointment to the Governing Board of the Pension Fund
Publicado: (2011)